Pharmacology Watch – April 1, 2018
April 1, 2018
View Issues
-
NOTICE: April 2018 was the final issue of this publication.
We will continue providing valuable clinical and pharmacological updates in Internal Medicine Alert and Primary Care Reports. -
Aspirin Matches Xarelto Efficacy Regarding VTE Prophylaxis After Knee or Hip Surgery
The authors of a recent study concluded that among hip or knee arthroplasty patients who receive five days of postoperative rivaroxaban, extended prophylaxis with aspirin was not significantly different from rivaroxaban in the prevention of symptomatic venous thromboembolism.
-
Comparing Treatments for Cancer-associated VTE
Researchers have determined that edoxaban was noninferior to dalteparin regarding the composite outcome of recurrent VTE or major bleeding, although recurrent VTE was lower and bleeding was higher with edoxaban.
-
What About Aspirin for PCI Patients?
Should clinicians continue using aspirin for patients with prior percutaneous coronary intervention who are undergoing noncardiac surgery? The answer appears to be yes based on the results of a new study from Canada.
-
Influenza A Renders This Year’s Flu Vaccine Ineffective
This year’s flu vaccine was only 36% effective, according to the CDC.
-
FDA Actions
In this section: The agency approves a new drug for prostate cancer and expands the indication for a non-small cell lung cancer treatment.